|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
2
|
Chen P, Liu Y, Wen Y and Zhou C: Non-small
cell lung cancer in China. Cancer Commun (Lond). 42:937–970. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Herbst RS, Morgensztern D and Boshoff C:
The biology and management of non-small cell lung cancer. Nature.
553:446–454. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel RL, Kratzer TB, Wagle NS, Sung H
and Jemal A: Cancer statistics, 2026. CA Cancer J Clin.
76:700432026.
|
|
5
|
Chinese Pharmacopoeia Commission, .
Pharmacopoeia of the People's Republic of China 2020 Edition. Vol
I. China Medical Science Press; Beijingpp479: 2020, (Standard No.
Zedoary Turmeric Oil).
|
|
6
|
Cui T, Li BY, Liu F and Xiong L: Research
progress on sesquiterpenoids of curcumae rhizoma and their
pharmacological effects. Biomolecules. 14:3872024. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhong M, Li Y, Wang H, Fan N, Chu X, Liu
L, Zhao C, Sun Y, Zhang S and Fu H: Integrated network pharmacology
and experimental validation reveal EGFR/p53/Bcl-2-mediated
anti-hepatocellular carcinoma effects of Zedoary Turmeric Oil. J
Ethnopharmacol. 352:1202412025. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou JL, Zheng JY, Cheng XQ, Xin GZ, Wang
SL and Xie T: Chemical markers' knockout coupled with
UHPLC-HRMS-based metabolomics reveals anti-cancer integration
effects of the curcuminoids of turmeric (Curcuma longa L.)
on lung cancer cell line. J Pharm Biomed Anal. 175:1127382019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cho HK, Park CG and Lim HB: Construction
of a synergy combination model for turmeric (Curcuma longa
L.) and black pepper (Piper nigrum L.) Extracts: Enhanced
anticancer activity against A549 and NCI-H292 human lung cancer
cells. Curr Issues Mol Biol. 46:5551–5560. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ashrafizadeh M, Najafi M, Makvandi P,
Zarrabi A, Farkhondeh T and Samarghandian S: Versatile role of
curcumin and its derivatives in lung cancer therapy. J Cell
Physiol. 235:9241–9268. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu YZ, Zhang Q, Wei XH, Jiang CX, Li XK,
Shang HC and Lin S: Multiple anti-inflammatory mechanisms of
Zedoary turmeric oil Injection against lipopolysaccharides-induced
acute lung injury in rats elucidated by network pharmacology
combined with transcriptomics. Phytomedicine. 106:1544182022.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang Z, Wang Z, Li J, Long J, Peng C and
Yan D: Network pharmacology-based dissection of the underlying
mechanisms of dyspnoea induced by Zedoary turmeric oil. Basic Clin
Pharmacol Toxicol. 130:606–617. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tong H, Yu M, Fei C, Ji D, Dong J, Su L,
Gu W, Mao C, Li L, Bian Z, et al: Bioactive constituents and the
molecular mechanism of Curcumae Rhizoma in the treatment of
primary dysmenorrhea based on network pharmacology and molecular
docking. Phytomedicine. 86:1535582021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang P, Zhang D, Zhou W, Wang L, Wang B,
Zhang T and Li S: Network pharmacology: Towards the artificial
intelligence-based precision traditional Chinese medicine. Brief
Bioinform. 25:bbad5182023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang W, Tong H, Zhang Z, Shao S, Liu D,
Li S and Yan Y: Transcription factor EGR1 promotes differentiation
of bovine skeletal muscle satellite cells by regulating MyoG gene
expression. J Cell Physiol. 233:350–362. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Z, Wang X, Guo Z, Liao H, Chai Y and
Wang Z and Wang Z: Reduning attenuates LPS-Induced human unmilical
vein endothelial cells (HUVECs) apoptosis through PI3K-AKT
signaling pathway. Front Pharmacol. 13:9213372022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2022. CA Cancer J Clin. 72:7–33.
2022.PubMed/NCBI
|
|
20
|
Jeon H, Wang S, Song J, Gill H and Cheng
H: Update 2025: Management of Non-Small-cell lung cancer. Lung.
203:532025. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li L, Xie Q, Bian G, Zhang B, Wang M, Wang
Y, Chen Z and Li Y: Anti-H1N1 viral activity of three main active
ingredients from zedoary oil. Fitoterapia. 142:1044892020.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu YZ, Zhang Q, Li H, Jiang CX, Li XK,
Shang HC and Lin S: Zedoary turmeric oil injection ameliorates lung
inflammation via platelet factor 4 and regulates gut microbiota
disorder in respiratory syncytial virus-infected young mice. Chin
Med. 19:832024. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu G, Shen Q, Jiang H, Ji O, Zhu L and
Zhang L: Curcumin inhibited the growth and invasion of human
monocytic leukaemia SHI-1 cells in vivo by altering MAPK and MMP
signalling. Pharm Biol. 58:25–34. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wei W, Rasul A, Sadiqa A, Sarfraz I,
Hussain G, Nageen B, Liu X, Watanabe N, Selamoglu Z, Ali M, et al:
Curcumol: From plant roots to cancer roots. Int J Biol Sci.
15:1600–1609. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ning N, Liu S, Liu X, Tian Z, Jiang Y, Yu
N, Tan B, Feng H, Feng X and Zou L: Curcumol inhibits the
proliferation and metastasis of melanoma via the
miR-152-3p/PI3K/AKT and ERK/NF-κB signaling pathways. J Cancer.
11:1679–1692. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang X, Qian J, Li L, Zhang X, Wei G, Lv
J, Qin F, Yu J, Xiao Y, Gong Z and Huo J: Curcumol improves
cisplatin sensitivity of human gastric cancer cells through
inhibiting PI3K/AKT pathway. Drug Dev Res. 81:1019–1025. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lyu Y, Feng W, Song J, Wang C, Fu Y, Zhao
B and Meng Y: Zedoarondiol inhibits human bronchial smooth muscle
cell proliferation through the CAV-1/PDGF signalling pathway. Sci
Rep. 14:131452024. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao Y, Cai J, Shi K, Li H, Du J, Hu D,
Liu Z and Wang W: Germacrone induces lung cancer cell apoptosis and
cell cycle arrest via the Akt/MDM2/p53 signaling pathway. Mol Med
Rep. 23:4522021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xie H, Su D, Zhang J, Ji D, Mao J, Hao M,
Wang Q, Yu M, Mao C and Lu T: Raw and vinegar processed Curcuma
wenyujin regulates hepatic fibrosis via bloking TGF-β/Smad
signaling pathways and up-regulation of MMP-2/TIMP-1 ratio. J
Ethnopharmacol. 246:1117682020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Syed Abdul Rahman SN, Abdul Wahab N and
Abd Malek SN: In vitro morphological assessment of apoptosis
induced by antiproliferative constituents from the rhizomes of
curcuma zedoaria. Evid Based Complement Alternat Med.
2013:2571082013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ye L, Chen X and Zhou F: EGFR-mutant
NSCLC: Emerging novel drugs. Curr Opin Oncol. 33:87–94. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Stella GM, Luisetti M, Inghilleri S, Cemmi
F, Scabini R, Zorzetto M and Pozzi E: Targeting EGFR in
non-small-cell lung cancer: Lessons, experiences, strategies.
Respir Med. 106:173–183. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Faes S and Dormond O: PI3K and AKT:
Unfaithful partners in cancer. Int J Mol Sci. 16:21138–21152. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cai F, Chen M, Zha D, Zhang P, Zhang X,
Cao N, Wang J, He Y, Fan X, Zhang W, et al: Curcumol potentiates
celecoxib-induced growth inhibition and apoptosis in human
non-small cell lung cancer. Oncotarget. 8:115526–115545. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shien K, Papadimitrakopoulou VA, Ruder D,
Behrens C, Shen L, Kalhor N, Song J, Lee JJ, Wang J, Tang X, et al:
JAK1/STAT3 activation through a proinflammatory cytokine pathway
leads to resistance to molecularly targeted therapy in Non-Small
cell lung cancer. Mol Cancer Ther. 16:2234–2245. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu Y, Ma H and Yao J: ERα, A key target
for cancer therapy: A review. Onco Targets Ther. 13:2183–2191.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Song Z, Yu X and Zhang Y: Mutation and
prognostic analyses of PIK3CA in patients with completely resected
lung adenocarcinoma. Cancer Med. 5:2694–2700. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dong RF, Zhu ML, Liu MM, Xu YT, Yuan LL,
Bian J, Xia YZ and Kong LY: EGFR mutation mediates resistance to
EGFR tyrosine kinase inhibitors in NSCLC: From molecular mechanisms
to clinical research. Pharmacol Res. 167:1055832021. View Article : Google Scholar : PubMed/NCBI
|
